Virlaza Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
A Case Report | Virlaza™ Improves Cardiopulmonary Recovery of Post-Covid-19 Patient
Virlaza™ Improves Cardiopulmonary Recovery of Post-Covid-19 Patient: A Case Report